Literature DB >> 21426160

Computer tools in the discovery of HIV-1 integrase inhibitors.

Chenzhong Liao1, Marc C Nicklaus.   

Abstract

Computer-aided drug design (CADD) methodologies have made great advances and contributed significantly to the discovery and/or optimization of many clinically used drugs in recent years. CADD tools have likewise been applied to the discovery of inhibitors of HIV-1 integrase, a difficult and worthwhile target for the development of efficient anti-HIV drugs. This article reviews the application of CADD tools, including pharmacophore search, quantitative structure-activity relationships, model building of integrase complexed with viral DNA and quantum-chemical studies in the discovery of HIV-1 integrase inhibitors. Different structurally diverse integrase inhibitors have been identified by, or with significant help from, various CADD tools.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21426160      PMCID: PMC3413319          DOI: 10.4155/fmc.10.193

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  111 in total

1.  Solution structure of the N-terminal zinc binding domain of HIV-1 integrase.

Authors:  M Cai; R Zheng; M Caffrey; R Craigie; G M Clore; A M Gronenborn
Journal:  Nat Struct Biol       Date:  1997-07

Review 2.  Computer-based de novo design of drug-like molecules.

Authors:  Gisbert Schneider; Uli Fechner
Journal:  Nat Rev Drug Discov       Date:  2005-08       Impact factor: 84.694

3.  National Cancer Institute Drug Information System 3D database.

Authors:  G W Milne; M C Nicklaus; J S Driscoll; S Wang; D Zaharevitz
Journal:  J Chem Inf Comput Sci       Date:  1994 Sep-Oct

4.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

5.  Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.

Authors:  Raveendra Dayam; Tino Sanchez; Omoshile Clement; Robert Shoemaker; Shizuko Sei; Nouri Neamati
Journal:  J Med Chem       Date:  2005-01-13       Impact factor: 7.446

6.  Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.

Authors:  Raveendra Dayam; Laith Q Al-Mawsawi; Zahrah Zawahir; Myriam Witvrouw; Zeger Debyser; Nouri Neamati
Journal:  J Med Chem       Date:  2008-02-19       Impact factor: 7.446

7.  A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase.

Authors:  Daria J Hazuda; Neville J Anthony; Robert P Gomez; Samson M Jolly; John S Wai; Linghang Zhuang; Thorsten E Fisher; Mark Embrey; James P Guare; Melissa S Egbertson; Joseph P Vacca; Joel R Huff; Peter J Felock; Marc V Witmer; Kara A Stillmock; Robert Danovich; Jay Grobler; Michael D Miller; Amy S Espeseth; Lixia Jin; I-Wu Chen; Jiunn H Lin; Kelem Kassahun; Joan D Ellis; Bradley K Wong; Wei Xu; Paul G Pearson; William A Schleif; Riccardo Cortese; Emilio Emini; Vincenzo Summa; M Katharine Holloway; Steven D Young
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

Review 8.  HIV-1 IN inhibitors: 2010 update and perspectives.

Authors:  Christophe Marchand; Kasthuraiah Maddali; Mathieu Métifiot; Yves Pommier
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

9.  Investigation of the structural requirement for inhibiting HIV integrase: QSAR study.

Authors:  Nigus Dessalew
Journal:  Acta Pharm       Date:  2009-03       Impact factor: 2.230

10.  In-Silico docking of HIV-1 integrase inhibitors reveals a novel drug type acting on an enzyme/DNA reaction intermediate.

Authors:  Andrea Savarino
Journal:  Retrovirology       Date:  2007-03-20       Impact factor: 4.602

View more
  4 in total

1.  HIV Drug Resistance and the Advent of Integrase Inhibitors.

Authors:  Peter K Quashie; Thibault Mesplède; Mark A Wainberg
Journal:  Curr Infect Dis Rep       Date:  2013-02       Impact factor: 3.725

Review 2.  Software and resources for computational medicinal chemistry.

Authors:  Chenzhong Liao; Markus Sitzmann; Angelo Pugliese; Marc C Nicklaus
Journal:  Future Med Chem       Date:  2011-06       Impact factor: 3.808

Review 3.  Novel therapeutic strategies targeting HIV integrase.

Authors:  Peter K Quashie; Richard D Sloan; Mark A Wainberg
Journal:  BMC Med       Date:  2012-04-12       Impact factor: 8.775

Review 4.  The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance.

Authors:  Mark A Wainberg
Journal:  Scientifica (Cairo)       Date:  2012-12-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.